Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1186/s12885-016-2636-z
Published Online: 2016-08-02
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Won, Brian
Mambetsariev, Isa
Salgia, Ravi http://orcid.org/0000-0001-9643-7626
License valid from 2016-08-02
